Clinical Coagulation, Malmö

301 – 310 of 659

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1000575?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
30
31
32
33
…
66
next »

2014
Mark Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity
Matino, D. ; Lillicrap, D. ; Astermark, Jan ^LU ; Dolan, G. ; Kessler, C. ; Lambert, T. ; Makris, M. ; O'Donnell, J. ; Pipe, S. and Santagostino, E. , et al. (2014) In Haemophilia 20(2). p.200-206
- Contribution to journal › Article
Mark Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.
Olsson, Anna ; Hellgren, Margareta ; Berntorp, Erik ^LU ; Ljung, Rolf ^LU and Baghaei, Fariba (2014) In Blood Coagulation and Fibrinolysis 25(5). p.471-475
- Contribution to journal › Article
Mark Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
Laros-van Gorkom, Britta Antonia Petra ; Falaise, Celine and Astermark, Jan ^LU (2014) In European Journal of Haematology 93. p.26-38
- Contribution to journal › Scientific review
Mark A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
Berntorp, Erik ^LU ; Shapiro, A D ; Waters, J and Astermark, Jan ^LU (2014) In Haemophilia 20(5). p.362-364
- Contribution to journal › Letter
Mark Outcome measures in haemophilia: a systematic review
Boehlen, Francoise ; Graf, Lukas and Berntorp, Erik ^LU (2014) In European Journal of Haematology 93. p.2-15
- Contribution to journal › Scientific review
Mark Managing Haemophilia for Life: 4th Haemophilia Global Summit
Astermark, Jan ^LU ; Dolan, G. ; Hilberg, T. ; Jimenez-Yuste, V. ; Laffan, M. ; Lassila, R. ; Lobet, S. ; Martinoli, C. and Perno, C. -F. (2014) In Haemophilia 20. p.1-20
- Contribution to journal › Scientific review
Mark Inflammatory plasma markers and risk for venous thromboembolism.
Sveinsdottir, Signy ^LU ; Svensson, Peter ^LU and Engström, Gunnar ^LU (2014) In Journal of Thrombosis and Thrombolysis 38(2). p.190-195
- Contribution to journal › Article
Mark Angiogenesis is increased in advanced haemophilic joint disease and characterized by normal pericyte coverage.
Zetterberg, Eva ^LU ; Palmblad, J ; Wallensten, R ; Morfini, M ; Melchiorre, D and Holmström, Eva M ^LU (2014) In European Journal of Haematology 92(3). p.256-262
- Contribution to journal › Article
Mark Red cell distribution width and risk for venous thromboembolism: A population-based cohort study.
Zöller, Bengt ^LU ; Melander, Olle ^LU ; Svensson, Peter ^LU and Engström, Gunnar ^LU (2014) In Thrombosis Research 133(3). p.334-339
- Contribution to journal › Article
Mark Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?
Berntorp, Erik ^LU ; Dolan, G ; Hermans, C ; Laffan, M ; Santagostino, E and Tiede, A (2014) In Haemophilia 20. p.1-11
- Contribution to journal › Article

« previous
1
…
30
31
32
33
…
66
next »